Clene Statistics

NASDAQ: CLNNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.92+0.05 (+1.29%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Clene by the numbers

Clene has a market capitalization of $55.7 million based on 14.21M shares outstanding. With trailing EPS of $-3.52, Clene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.3% below its 50-day average and 27.2% below its 200-day average.

Average daily trading volume is 100.64K shares, or about $394,524 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CLNN valuation vs. peer median

CLNN compared with the median of 8 peer companies
Metric	CLNN	Peer median	Difference
Market cap	$55.72M	$54.78M	+2%
Avg. volume	100.64K	670.12K	-85%

Peer median across 8 companies: ZYBT, HYPD, TLPH, MREO, EDSA, ALDX, ACET, ANVS.

Valuation

Market cap: $55.72M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-3.52
Shares outstanding: 14.21M

Price and trading

Previous close: 3.87
Open: 3.85
Day range: 3.71 – 4.01
52-week range: 3.25 – 13.50
52-week change: -56.78%
50-day moving average: 4.32
200-day moving average: 5.39
Beta: —
Volume: 40.48K
Average volume: 100.64K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Aug 13, 2025

Additional statistics

Market Cap: 55.72M
Forward Pe: -1.61
Eps: -3.52
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 13.50
Week52 Low: 3.25
Avg Volume: 100.64K
Shares Outstanding: 14.21M
Ma50: 4.32
Ma200: 5.39
Earnings Date: Aug 13, 2025
Pct From52w High: -70.96%
Pct From52w Low: 20.62%